Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Almac has received a renewal of its GMP/GDP certification following the successful regulatory inspection by the Health Sciences Authority (HSA) of its facility in Singapore.
read more
Tuesday, February 28, 2012
Almac, a leading provider of contract services to the global Pharmaceutical and Biotech industries, has addressed a surge in clinical outsourcing by acquiring two new pieces of encapsulation equipment at their North American headquarters in Souderton...
read more
Thursday, October 24, 2013
With the opening of a new commercial packaging facility in the US and enhanced processing capabilities at the company’s Headquarters in Craigavon, UK, investments in the past year has substantially transformed the commercial business unit of Almac.
read more
Tuesday, January 07, 2014
Almac Group Limited (“Almac”) and Key Organics Limited (“Key Organics”) today announced that they have entered into an exclusive supply & marketing agreement.
read more
Almac Group has announced additional expansion plans at its Athlone facility.
read more
Almac is pleased to announce the launch of a mobile optimised version of its website, enabling biotech and pharma clients and prospective customers to access Almac’s content whilst out of the office with only a mobile to hand. The new mobile ready ...
read more
Almac has brought a second stream for High Throughput GMP Peptide manufacturing online.
read more
Tuesday, November 15, 2022
Almac Group announced that after the successful pre-approval inspection (PAI) of its Pharma Services’ operations located in Audubon, Pennsylvania by the FDA, the site has received product approval from the US FDA, UK Medicines and Healthcare products...
read more
Almac’s diagnostics business unit today announced that it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing them to receive patient samples for clinical testing from New York.
read more
Almac has been recognised for its cutting edge technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (bmi).
read more
As the Industry faces the tightest ever new heavy metal mandates from the FDA, stipulating the control and documentation, where appropriate, of all elemental impurities in drug products, drug substances and excipients, Almac has invested in state of ...
read more
Wednesday, October 05, 2022
Almac Clinical Services announced a new state-of-the-art Cryogenic Service Solution within its Durham, North Carolina campus to support cell and gene therapies.
read more
Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following ...
read more
Wednesday, March 04, 2020
Alopexx Oncology has entered into an exclusive license agreement with Beijing Shenogen Pharma Group to develop and commercialize DI-Leu16-IL2 in China and other parts of Asia.
read more
Thursday, January 12, 2023
lora Pharmaceuticals announced that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in Fort Worth, TX.
read more